113 related articles for article (PubMed ID: 953955)
1. Treatment of advanced malignancy with CCNU (NSC 79037): a phase II cooperative study with long-term follow up.
Cruz AB; Metter G; Armstrong DM; Aust JB; Fletcher WS; Wilson WL; Richardson JD
Cancer; 1976 Sep; 38(3):1069-76. PubMed ID: 953955
[TBL] [Abstract][Full Text] [Related]
2. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
Stolinsky DC; Bull FE; Pajak TF; Bateman JR
Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
[TBL] [Abstract][Full Text] [Related]
3. A clinical trial of CCNU (1-(2 chloroethyl)-3-cyclohexyl-1-nitrosourea) (NSC 79037) in advanced ovarian carcinoma.
Sasaki TM; McConnell DB; Moseley HS; Merhoff GC; Fletcher WS
J Surg Oncol; 1975; 7(5):347-50. PubMed ID: 1100915
[TBL] [Abstract][Full Text] [Related]
4. The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study.
Hansen HH; Selawry OS; Pajak TF; Spurr CL; Falkson G; Brunner K; Cuttner J; Nissen NI; Holland JF
Cancer; 1981 Jan; 47(1):14-8. PubMed ID: 7006789
[TBL] [Abstract][Full Text] [Related]
5. Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma.
Maurice P; Glidewell O; Jacquillat C; Silver RT; Carey R; Pas AT; Cornell CJ; Burningham RA; Nissen NI; Holland JF
Cancer; 1978 May; 41(5):1658-63. PubMed ID: 348294
[TBL] [Abstract][Full Text] [Related]
6. CCNU and bleomycin in the treatment of cancer: a Southwest Oncology Group Study.
Hoogstraten B; Haas CD; Haut A; Talley RW; Rivkin S; Isaacs BL
Med Pediatr Oncol; 1975; 1(2):95-106. PubMed ID: 59307
[TBL] [Abstract][Full Text] [Related]
7. 1-2(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU, NSC-79037): a comparison of drug administration at four-week and six-week intervals.
Broder LE; Hansen HH
Eur J Cancer (1965); 1973 Feb; 9(2):147-52. PubMed ID: 4717488
[No Abstract] [Full Text] [Related]
8. 5-fluorouracil versus CCNU in the treatment of metastatic prostatic cancer.
Tejada F; Eisenberger MA; Broder LA; Cohen MH; Simon R
Cancer Treat Rep; 1977 Nov; 61(8):1589-90. PubMed ID: 922761
[No Abstract] [Full Text] [Related]
9. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
Alberto P; Barrelet L; Chapuis B; Garcia B
Eur J Cancer (1965); 1975 Nov; 11(11):795-9. PubMed ID: 767111
[No Abstract] [Full Text] [Related]
10. Clinical toxicity of combined modality treatment with nitrosourea derivatives for central nervous system tumors.
Robustelli della Cuna G; Paoletti P; Bernardo G; Knerich R; Butti G; Cuzzoni Q
Neurosurgery; 1982 Sep; 11(3):408-11. PubMed ID: 6290930
[TBL] [Abstract][Full Text] [Related]
11. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
Cedermark BJ; Didolkar MS; Elias EG
Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with CCNU (NSC-79037) and 5-(3, 3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196).
Chang H; Freireich EJ; Khaliq A; Einhorn L; Gottlieb JA
Cancer Chemother Rep; 1975; 59(4):769-71. PubMed ID: 1100230
[No Abstract] [Full Text] [Related]
13. Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung.
Wilson WL; Andrews NC; Frelick RW; Nealon TF; Bick RL; Adams T
Cancer Treat Rep; 1976 Mar; 60(3):269-71. PubMed ID: 816467
[No Abstract] [Full Text] [Related]
14. Mechlorethamine (NSC-762) plus CCNU (NSC-79037) in the treatment of inoperable squamous and large cell carcinoma of the lung.
Edmonson JH; Lagakos S; Stolbach L; Perlia CP; Bennett JM; Mansour EG; Horton J; Regelson W; Cummings FJ; Israel L; Brodsky I; Shnider BI; Creech R; Carbone PP
Cancer Treat Rep; 1976 May; 60(5):625-7. PubMed ID: 186183
[No Abstract] [Full Text] [Related]
15. Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer. A Southwest Oncology Group study.
Gagliano RG; Panettiere FJ; Haas CD; Baker L; Hewlett J; Stuckey WJ; O'Bryan RM; Bottomley R; Heilburn LK
Cancer Clin Trials; 1981; 4(4):401-5. PubMed ID: 7318121
[TBL] [Abstract][Full Text] [Related]
16. Nitrosourea combination chemotherapy: 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (methyl-CCNU) and cyclophosphamide.
Lokich JJ; Skarin AT
Oncology; 1975; 32(3-4):169-74. PubMed ID: 768852
[TBL] [Abstract][Full Text] [Related]
17. [Experience with combination therapy of solid tumors using 1-(2-chloroethyl)-3-cyclohexyl-nitrosourea--CCNU].
Robustelli Della Cuna G
G Ital Chemioter; 1980; 27(1):15-8. PubMed ID: 7286538
[No Abstract] [Full Text] [Related]
18. Treatment of brain giomas with high dose of CCNU and autologous bone marrow transplantation.
Hildebrand J; Badjou R; Collard-Ronge E; Delforge A; Malarme M; Spiro T; Sztern B; Vandensteene A; Stryckmans PA
Biomedicine; 1980 May; 32(2):71-5. PubMed ID: 6992877
[TBL] [Abstract][Full Text] [Related]
19. Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel.
Horton J; Mittelman A; Taylor SG; Jurkowitz L; Bennett JM; Ezdinli E; Colsky J; Hanley JA
Cancer Chemother Rep; 1975; 59(2 Pt 1):333-40. PubMed ID: 125147
[TBL] [Abstract][Full Text] [Related]
20. A phase I trial of weekly lomustine in patients with advanced cancer.
Koller CA; Gorski CC; Benjamin RS; Legha SS; Papadopoulos NE; Plager C
Cancer; 1994 Jan; 73(1):236-9. PubMed ID: 8275432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
